Translating Clinical Science into Authoritative Documents
The pharmaceutical landscape in Basel, a global epicentre for life sciences innovation and drug development, demands documents of exceptional scientific accuracy, regulatory stringency, and communicative clarity. For clinical scientists, regulatory affairs professionals, and pharmaceutical sponsors, the challenge is to produce clinical trial documents and regulatory submissions that are both methodologically impeccable and compliant with global health authority standards. Securing regulatory approval and ensuring clear scientific communication necessitates writing that convincingly demonstrates data integrity, robust statistical analysis, and a persuasive benefit-risk narrative. Within this high-stakes environment, managing the multifaceted demands of medical writing—from complex clinical study reports (CSRs) to concise investigator brochures—can be formidable. Our Medical Writing Services provide a structured, end-to-end pathway to regulatory and publication success by offering expert authoring, strategic data presentation, and bespoke support aligned with each product's development phase. By engaging our services, sponsors gain access to industry-standard writing methodologies, critical quality control, and professional frameworks that ensure every document is meticulously crafted, scientifically robust, and regulatory authoritative, enabling confident submission and clear communication.
Contemporary Medical Communication Imperatives and Complexities
Current regulatory and publishing analyses reveal that a considerable proportion of pharmaceutical sponsors encounter significant hurdles with pivotal document components, including constructing coherent narratives from multifaceted clinical data, adhering to evolving ICH guidelines, and clearly articulating complex pharmacokinetic and safety findings. These obstacles frequently result in regulatory information requests, submission delays, and potential setbacks in development timelines. Our services are meticulously engineered to mitigate these issues, guaranteeing clients receive structured authoring direction and professional partnership at each developmental phase. We assist industry and academic professionals by:
- Delivering phased guidance on structuring comprehensive regulatory documents and scientific manuscripts, organising complex efficacy and safety data with logical coherence and persuasive impact.
- Furnishing detailed strategies for ensuring strict adherence to ICH E3, CONSORT, and other mandated reporting guidelines, alongside specific formatting requirements of target health authorities or journals.
- Guaranteeing rigorous consistency in terminology, data presentation, and statistical reporting across all documents within a regulatory dossier or publication portfolio.
- Substantially reducing the internal resource burden and time involved in developing high-stakes regulatory and clinical documents while elevating overall scientific quality and compliance.
Through these focused methodologies, our support transforms the medical writing process, enabling clients to concentrate on core scientific and clinical development while delegating the specialised craft of professional scientific documentation to dedicated specialists.
Dr.
Jurema Rasinger
About
Dr. Jurema Rasinger is a preeminent authority in Pharmacy and Scientific & Medical Research with 16 years of dedicated industry and academic experience and a PhD in Pharmaceutical Sciences. Esteemed for her command of the medical writing discipline, Dr. Rasinger specialises in the authoritative communication of clinical pharmacology, PK/PD modelling, and translational medicine data. They employ advanced analytical tools, including Phoenix WinNonlin and NONMEM, to underpin scientifically precise and regulatorily sound documents. Dr. Rasinger's work encompasses authoring and reviewing critical documents such as clinical study reports (CSRs), protocol amendments, integrated summaries, and high-impact manuscripts for leading journals. With an approach that is both supportive and exacting, she cultivates documentation excellence. Committed to advancing drug development communication, Dr. Rasinger mentors writing teams and upholds the highest standards of clarity, accuracy, and integrity in pharmaceutical writing. Her extensive career, deeply embedded in the Basel ecosystem, renders her an indispensable partner for navigating the region's stringent regulatory and scientific expectations.
Our Comprehensive Medical Writing Services
Clinical Trial Protocol & Report Authoring
We offer expert partnership in drafting and finalising robust clinical trial protocols, clinical study reports (CSRs), and synopses. Our writing ensures these foundational documents are scientifically rigorous, ethically sound, and fully aligned with ICH-GCP and specific regulatory agency expectations.
Regulatory Submission Document Preparation
Our team assists in authoring and compiling core components of regulatory dossiers, including clinical overviews (ICH E3), integrated summaries of efficacy and safety (ISE/ISS), and common technical document (CTD) modules. We ensure a consistent, persuasive narrative that supports the product's benefit-risk profile.
Pharmacokinetic/Pharmacodynamic (PK/PD) & Statistical Reporting
We provide specialised writing for complex PK/PD analysis reports, statistical analysis plans (SAPs), and output summaries. This ensures intricate modelling data and statistical findings are communicated with precision, clarity, and direct relevance to clinical interpretation.
Scientific Manuscripts & Conference Communications
We support the development of publication-ready manuscripts for peer-reviewed journals, as well as abstracts, posters, and slide decks for scientific conferences, translating clinical trial results into impactful communications for the broader scientific community.
Strategic Advantages
Pharmaceutical companies, biotech companies, and clinical researchers utilising our services experience a comprehensive array of benefits that enhance both regulatory success and scientific outreach:
- Regulatory and Journal Compliance Assurance – Each document is crafted to adhere precisely to the latest ICH guidelines, health authority specifications, and journal author instructions, minimising the risk of queries or rejection on technical grounds.
- Enhanced Scientific Credibility and Clarity – Expert medical writing elevates the presentation of complex data, ensuring arguments are logically structured, evidence-based, and accessible to regulatory reviewers, clinicians, and scientists.
- Optimised Development Timelines and Resource Allocation – Professional authoring and management of the writing process accelerate document turnaround, freeing internal teams to focus on strategic development and clinical execution.
- Consistency and Quality Across Document Portfolios – A centralised writing service guarantees terminological and stylistic consistency across all documents for a given product, strengthening the overall regulatory narrative.
- Confidence in Global Submissions – Sponsors gain assurance that their submission documents meet the highest international standards of medical writing, facilitating smoother interactions with agencies like Swiss medic, EMA, and FDA.
By leveraging these strategic advantages, sponsors and researchers not only improve the quality and speed of their documentation but also build a stronger, more credible case for their products, supporting successful market entry and scientific recognition.
Disciplinary and Document-Type Applications
- Early Clinical Development (Phase I/II) – Protocol writing for first-in-human and proof-of-concept studies, informed consent forms (ICFs), and early-phase clinical study reports.
- Late-Stage and Pivotal Trials (Phase III/IV) – Authoring of large, complex CSRs, protocols, and documents supporting marketing authorisation applications (MAAs) and new drug applications (NDAs).
- Clinical Pharmacology & Biomarker Science – Specialised reports on PK/PD analyses, bioequivalence studies, and biomarker validation, communicating complex analytical data to regulatory and scientific audiences.
- Patient Safety and Regulatory Affairs – Development of periodic safety update reports (PSURs), risk management plans (RMPs), and responses to health authority queries.
Each service is customised to the specific requirements of Basel-based sponsors, from global pharmaceutical headquarters to innovative biotech startups, ensuring maximum regulatory impact, efficient resource use, and the achievement of development and communication objectives.
The Future of Medical Communication: Precision Meets Persuasion
Contemporary medical writing transcends mere data transcription; it increasingly necessitates strategic narrative design, visual data communication, and adherence to global transparency mandates. Our services empower clients to:
- Implement clear, compelling narratives that transform complex clinical datasets into persuasive evidence of safety and efficacy for regulatory decision-makers.
- Navigate the evolving requirements of open science and clinical trial transparency (e.g., EU CTR) with accurately drafted registrations and summary results.
- Apply consistent, audience-tailored approaches to communicate the same core data to regulators, scientists, healthcare professionals, and, where appropriate, patients.
- Produce submission-ready documents that are scientifically flawless, regulatorily compliant, and strategically positioned to support successful product development and lifecycle management.
By integrating these forward-looking approaches, our services ensure that Basel’s pharmaceutical and biotech community remains at the forefront of global medical communication, equipped to advance new therapies with documentation that meets the most rigorous international benchmarks.
